scholarly journals Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline

2011 ◽  
Vol 1 (2) ◽  
pp. 60-71 ◽  
Author(s):  
George Rodrigues ◽  
Gregory M.M. Videtic ◽  
Ranjan Sur ◽  
Andrea Bezjak ◽  
Jeffrey Bradley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Radiation Oncology ◽  
Evidence Based ◽  
Thoracic Radiotherapy ◽  
American Society

Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

2015 ◽  
Vol 33 (18) ◽  
pp. 2100-2105 ◽  
Author(s):  
Andrea Bezjak ◽  
Sarah Temin ◽  
Gregg Franklin ◽  
Giuseppe Giaccone ◽  
Ramaswamy Govindan ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Radiation Oncology ◽  
Locally Advanced ◽  
Small Cell ◽  
Evidence Based ◽  
Consolidation Therapy ◽  
Small Cell Lung ◽  
American Society

Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on external-beam radiotherapy for patients with locally advanced non–small-cell lung cancer (NSCLC). Because of its relevance to the American Society of Clinical Oncology (ASCO) membership, ASCO endorsed the guideline after applying a set of procedures and a policy that are used to critically examine and endorse guidelines developed by other guideline development organizations. Methods The ASTRO guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor. On favorable review, an ASCO expert panel was convened and endorsed the guideline. The ASCO guideline approval body, the Clinical Practice Guideline Committee, approved the final endorsement. Results The recommendations from the ASTRO guideline, published in Practical Radiation Oncology, are clear, thorough, and based on the most relevant scientific evidence. The ASCO Endorsement Panel endorsed the guideline and added qualifying statements. Recommendations For curative-intent treatment of locally advanced NSCLC, concurrent chemoradiotherapy improves local control and overall survival compared with sequential chemotherapy followed by radiation. The standard dose-fractionation of radiation is 60 Gy given in 2-Gy once-daily fractions over 6 weeks. There is no role for the routine use of induction therapy before chemoradiotherapy. Current data fail to support a clear role for consolidation therapy after chemoradiotherapy; however, consolidation therapy remains an option for patients who did not receive full systemic chemotherapy doses during radiotherapy. Important questions remain about the ideal concurrent chemotherapy regimen and optimal management of patients with resectable stage III disease.

American Society of Plastic Surgeons Evidence-Based Clinical Practice Guideline Revision: Reduction Mammaplasty

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Galen Perdikis ◽  
Claire Dillingham ◽  
Stefanos Boukovalas ◽  
Adeyemi A. Ogunleye ◽  
Francisco Casambre ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Reduction Mammaplasty ◽  
Evidence Based ◽  
American Society
Sign in / Sign up

Export Citation Format

Share Document